Showing 13,061 - 13,080 results of 39,795 for search '(( 5 ((wt decrease) OR (mean decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.17s Refine Results
  1. 13061
  2. 13062
  3. 13063

    Individual data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  4. 13064

    Household data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  5. 13065

    Persons with epilepsy data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  6. 13066

    Ivermectin coverage in 2019 and 2021. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  7. 13067

    Individual data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  8. 13068

    Household data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  9. 13069

    Persons with epilepsy data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  10. 13070

    PRISMA flowchart of the included studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  11. 13071

    Characteristics of Included Studies. by Gaelle Salame (21077899)

    Published 2025
    “…</p><p>The combined data showed that patients receiving immunotherapy had higher C-peptide levels (Mean Difference (MD) = 1.51; 95% Confidence Interval (CI): [-2.56, 5.58]); however, this difference was not statistically significant (p = 0.42). …”
  12. 13072
  13. 13073

    SRSF5 regulates alternative splicing of <i>DMTF1</i> pre-mRNA through modulating SF1 binding by Jialiang Li (31220)

    Published 2021
    “…Upon SRSF5 knockdown, we observed significantly decreased <i>DMTF1β</i> and <i>γ</i> ratios of endogenous transcripts. …”
  14. 13074
  15. 13075
  16. 13076
  17. 13077
  18. 13078
  19. 13079
  20. 13080

    RpoS and Indole Signaling Control the Virulence of <i>Vibrio anguillarum</i> towards Gnotobiotic Sea Bass (<i>Dicentrarchus labrax</i>) Larvae by Xuan Li (137217)

    Published 2014
    “…Deletion of <i>rpoS</i> resulted in increased expression of the indole biosynthesis gene <i>tnaA</i> and in increased production of indole. Both <i>rpoS</i> deletion and the addition of exogenous indole (50–100 µM) resulted in decreased biofilm formation, exopolysaccharide production (a phenotype that is required for pathogenicity) and expression of the exopolysaccharide synthesis gene <i>wbfD</i>. …”